Currently Viewing Posts Tagged eficacia

The appearance of angiotensin receptor blockers (ARBs) amongst the therapeutic options in the treatment of cardiovascular diseases (CVDs) was a new milestone in the history of hypertension treatment. It further widened the range of possibilities for personalized therapy, especially for patients who cannot tolerate the use of angiotensin converting enzyme inhibitors (ACEIs). Continue reading “Comparative Efficacy and Safety of the Angiotensin Receptor Blockers (ARBs)”